Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Molecular diversity

Recently, various computational methods have been proposed to find new therapeutic applications of the existing drugs. The Multimodal Restricted Boltzmann Machine approach (MM-RBM), which has the capability to connect the information about the multiple modalities, can be applied to the problem of drug repurposing. The present study utilized MM-RBM to combine two types of data, including the chemical structures data of small molecules and differentially expressed genes as well as small molecules perturbations. In the proposed method, two separate RBMs were applied to find out the features and the specific probability distribution of each datum (modality). Besides, RBM was used to integrate the discovered features, resulting in the identification of the probability distribution of the combined data. The results demonstrated the significance of the clusters acquired by our model. These clusters were used to discover the medicines which were remarkably similar to the proposed medications to treat COVID-19. Moreover, the chemical structures of some small molecules as well as dysregulated genes' effect led us to suggest using these molecules to treat COVID-19. The results also showed that the proposed method might prove useful in detecting the highly promising remedies for COVID-19 with minimum side effects. All the source codes are accessible using

Hooshmand Seyed Aghil, Zarei Ghobadi Mohadeseh, Hooshmand Seyyed Emad, Azimzadeh Jamalkandi Sadegh, Alavi Seyed Mehdi, Masoudi-Nejad Ali


COVID-19, Deep learning, Drug repurposing, Multimodal data fusion, Restricted Boltzmann machine